Anthropic IPO Catalyst Play — Sell $77.50 Put, March 2027 Expiration
TRADE SUMMARY: Sell cash-secured put on Zoom Communications (ZM) at the $77.50 strike, March 2027 expiration, collecting approximately $11.00 in premium ($1,100 per contract). This trade captures elevated implied volatility ahead of the expected Anthropic PBC IPO in Q4 2026 while providing a 15% downside cushion to break-even.
1. Investment Thesis
Zoom Communications (ZM) is the most concentrated publicly-traded proxy for Anthropic PBC exposure. Per the companion report (Anthropic PBC — Pre-IPO Investment Exposure Analysis):
- Zoom invested ~US$51M in Anthropic in May 2023 at ~US$4.5B valuation
- At current US$380B private valuation, this stake is estimated at US$2–4 billion (Baird Research)
- This represents 8–16% of Zoom’s ~US$25B market capitalisation
- At an IPO valuation of US$500B+, the stake could reach US$5–7B (~20% of ZM market cap)
- Baird analyst William Power maintains Outperform rating with US$95 price target
The Anthropic IPO is no longer speculative. Bloomberg reported on 27 March 2026 that Anthropic is considering going public as early as October 2026, with bankers expecting a raise exceeding US$60 billion.
1.1 Why This Trade Works
- If Anthropic IPOs successfully (base case): ZM rallies on stake revaluation. Put expires worthless. Full premium retained.
- If ZM stays range-bound: Time decay (theta) erodes the put value. Premium retained at expiry.
- If ZM declines moderately: Break-even at $66.50 provides a 15% cushion — at that price, you’re buying ZM’s core business at an extreme discount after backing out cash and the Anthropic stake.
2. Trade Specification
| Parameter | Detail |
|---|---|
| Underlying | Zoom Communications Inc (NASDAQ: ZM) |
| Current Price | $78.21 (as of 28 March 2026) |
| Strategy | Sell Cash-Secured Put (CSP) |
| Strike Price | $77.50 |
| Expiration | 19 March 2027 (~356 days to expiry) |
| Premium (Bid) | $11.00 per share |
| Premium Collected | $1,100 per contract |
| Cash Collateral Required | $7,750 per contract |
| Effective Cost Basis (if assigned) | $66.50 |
| Break-Even Price | $66.50 |
| Downside Cushion | 15.0% from current price |
| Return on Capital (max) | 14.2% ($1,100 / $7,750) |
| Annualised Return | ~14.6% (356-day hold) |
| Max Profit | $1,100 per contract |
| Max Loss | $5,550 per contract (ZM → $0, theoretical) |
3. Scenario Analysis
3.1 Outcome Matrix
| ZM Price at Expiry | Outcome | P&L per Contract | Return on Capital |
|---|---|---|---|
| $95.00 (Baird PT) | Put expires worthless | +$1,100 | +14.2% |
| $85.00 | Put expires worthless | +$1,100 | +14.2% |
| $78.21 (unchanged) | Put expires worthless | +$1,100 | +14.2% |
| $77.50 (at the money) | Put expires worthless / marginal | +$1,100 | +14.2% |
| $72.00 | Assigned, unrealised loss | +$550 | +7.1% |
| $66.50 (break-even) | Assigned, break-even | $0 | 0% |
| $60.00 | Assigned, loss | −$650 | −8.4% |
| $55.00 | Assigned, loss | −$1,150 | −14.8% |
| $50.00 | Assigned, loss | −$1,650 | −21.3% |
3.2 Probability Assessment
| Scenario | Probability | Rationale |
|---|---|---|
| ZM > $77.50 (max profit) | 60–65% | Anthropic IPO catalyst + cash floor + analyst coverage |
| ZM $66.50–$77.50 (partial profit) | 20–25% | IPO delay or market correction, but fundamentals intact |
| ZM < $66.50 (loss) | 10–15% | IPO cancelled + ZM core business deterioration + broad market crash |
4. Valuation Floor Analysis
4.1 Sum-of-Parts at Assignment ($66.50 effective cost)
At an effective cost basis of $66.50/share, the implied ZM market cap is approximately $20.8B:
| Component | Estimated Value | Per Share (~313M shares) |
|---|---|---|
| Cash & investments | $7.9B | $25.24 |
| Anthropic stake (conservative) | $2.0B | $6.39 |
| Implied core business value | $10.9B | $34.87 |
The core Zoom business generated ~$4.6B in trailing revenue with ~38% FCF margins (~$1.75B FCF). At $10.9B implied value: 6.1x EV/Revenue and 6.2x EV/FCF — extremely cheap, well below peer average of 20–25x.
4.2 Anthropic Upside Scenarios
| Anthropic Valuation | Est. ZM Stake Value | % of ZM Market Cap |
|---|---|---|
| $380B (current private) | $2–4B | 8–16% |
| $500B (conservative IPO) | $4–5B | 16–20% |
| $600B (bull case IPO) | $5–7B | 20–28% |
| $750B+ (blue sky) | $7–9B | 28–36% |
5. Catalyst Timeline
| Date | Event | Impact on ZM Put |
|---|---|---|
| May 2026 | ZM Q4 FY2026 earnings | Revenue/guidance update; Anthropic mark-to-market |
| Jun–Aug 2026 | Anthropic IPO roadshow begins | Speculation drives ZM higher; put decays faster |
| Aug 2026 | ZM Q1 FY2027 earnings | Last earnings before expected IPO |
| Oct 2026 | Anthropic IPO (expected) | Primary catalyst — stake crystallisation event |
| Nov 2026 | ZM Q2 FY2027 earnings | Post-IPO stake revaluation on balance sheet |
| Mar 2027 | Put expiration | Final settlement |
The March 2027 expiry is strategically chosen: it captures the full Anthropic IPO catalyst window (Oct 2026) with 5 months of buffer beyond.
6. Risk Assessment
| Risk | Severity | Mitigation |
|---|---|---|
| Anthropic IPO delayed to 2027+ | Medium | Put still has time value; ZM cash floor supports $60s valuation |
| Anthropic IPO cancelled | Low | ZM stake still marked at private valuation; no write-down unless distressed |
| ZM core business deterioration | Medium | Monitor quarterly revenue trends; 38% FCF margin provides buffer |
| Broad market crash | Medium | $66.50 break-even = 15% cushion; ZM’s $7.9B cash is defensive |
| Anthropic valuation haircut at IPO | Low-Medium | Even at 30% discount ($266B), ZM stake still worth $1.4–2.8B |
| Early assignment risk | Low | Unlikely when significant time value remains |
7. Position Sizing Guidance
| Account Size | Suggested Contracts | Capital Required | Max Profit | Max Risk (to $50) |
|---|---|---|---|---|
| $25,000 | 1–2 | $7,750–$15,500 | $1,100–$2,200 | $1,650–$3,300 |
| $50,000 | 3–4 | $23,250–$31,000 | $3,300–$4,400 | $4,950–$6,600 |
| $100,000 | 5–8 | $38,750–$62,000 | $5,500–$8,800 | $8,250–$13,200 |
Recommendation: Do not allocate more than 30% of available account capital to this single position. While the thesis is strong, concentration risk in a single-catalyst trade should be managed.
8. Trade Management Rules
8.1 Profit Taking
- At 50% profit ($550): Consider closing early if reached within 3–4 months — locks in gains and frees capital
- At 75% profit ($825): Strong close candidate, especially if Anthropic IPO is confirmed and ZM has rallied
- At expiry: Let expire if OTM; full premium retained
8.2 Loss Management
- If ZM drops below $70: Evaluate rolling down and out (e.g., roll to Jun 2027 $70P) for a net credit
- If ZM drops below $65: Accept assignment only if still bullish on Anthropic thesis; otherwise close for a loss
- If Anthropic IPO is officially cancelled: Close the position regardless of P&L — the primary catalyst is gone
8.3 Key Dates to Monitor
- ZM earnings dates (quarterly)
- Any Anthropic IPO filing (S-1) announcements
- Anthropic funding round news (further valuation changes)
- Broader market volatility events
9. Conclusion
Selling the ZM $77.50 put expiring March 2027 at $11.00 premium is a high-conviction, catalyst-driven income trade. The Anthropic IPO — now actively in preparation for Q4 2026 — provides a clear, time-bound catalyst that the March 2027 expiry fully captures.
The risk/reward is favourable:
- Best case: Anthropic IPOs, ZM rallies to $90+, put expires worthless → +14.2% return
- Base case: ZM stays range-bound, time decay works in your favour → +14.2% return
- Worst case: ZM drops 15%+ to break-even, but at $66.50 you own ZM at a deep discount to intrinsic value with $7.9B cash + $2B+ Anthropic stake backing you
Trade: Sell ZM $77.50P Mar 2027 @ $11.00. Collect $1,100/contract. Cash required: $7,750/contract.
Disclaimer: This report is for informational and research purposes only. It does not constitute investment advice. All figures are estimates based on publicly available information and current option chain pricing. Options involve risk of loss. Past performance does not guarantee future results. Investors should conduct their own due diligence.
Companion Report: Anthropic PBC — Pre-IPO Investment Exposure Analysis (27 March 2026)